Address correspondence to Dr Stewart J. Tepper, Dartmouth Headache Center, Neurology Department, Dartmouth-Hitchcock Medical Center, 1 Medical Center Dr, Lebanon, NH 03756, [email protected].
RELATIONSHIP DISCLOSURE: Dr Tepper has received personal compensation as editor-in-chief of the American Headache Society journal Headache Currents and has received personal compensation as a lecturer for CME. Dr Tepper has received personal compensation as a consultant for Acorda Therapeutics; Alder BioPharmaceuticals, Inc; Allergan; Amgen Inc; Autonomic Technologies, Inc; CEFALY Technology; Charleston Laboratories, Inc; DeepBench; Dr. Reddy’s Laboratories Ltd; ElectroCore, LLC; Eli Lilly and Company; eNeura Inc; Gerson Lehrman Group, Inc; Guidepoint Global, LLC; Impax; Neurolief Ltd; Novartis AG; Pfizer Inc; Scion NeuroStim LLC; Slingshot Insights; Supernus Pharmaceuticals, Inc; Teva Pharmaceutical Industries Ltd; and Zosano Pharma Corporation.Continued on page 1178 Dr Tepper receives research/grant support paid to his employer (no personal compensation) from Alder BioPharmaceuticals, Inc; Allergan; Amgen Inc; Autonomic Technologies, Inc; Avanir Pharmaceuticals, Inc; Dr. Reddy’s Laboratories Ltd; ElectroCore, LLC; eNeura Inc; Scion NeuroStim LLC; Teva Pharmaceutical Industries Ltd; and Zosano Pharma Corporation. Dr Tepper has stock options from Autonomic Technologies, Inc and receives royalties from Springer.
UNLABELED USE OF PRODUCTS/INVESTIGATIONAL USE DISCLOSURE: Dr Tepper discusses the unlabeled/investigational use of all listed medications for the treatment of neuralgias.
CONTINUUM AUDIO INTERVIEW AVAILABLE ONLINE